Literature DB >> 2169495

Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.

B Watson1, P M Keller, R W Ellis, S E Starr.   

Abstract

Humoral and cell-mediated immune responses were determined in seronegative children immunized with live attenuated Oka strain varicella vaccine. At 2 weeks after immunization, 80% of children had detectable lymphocyte proliferation to varicella-zoster virus (VZV) antigens, while only 40% had antibodies to VZV as detected by ELISA. By 6 weeks after immunization, 97% of children seroconverted, and 95% of these responded to VZV antigens in the proliferation assay. A high proportion of immunized children also responded in the proliferation assay to purified glycoproteins I, II, and III of VZV. These results indicate that most children develop a broad cell-mediated immune response to VZV antigens within weeks after immunization with varicella vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169495     DOI: 10.1093/infdis/162.4.794

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.

Authors:  A Weinberg; A R Hayward; H B Masters; I A Ogu; M J Levin
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.

Authors:  A Vafai; W N Yang
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.

Authors:  Z Huang; A Vafai; J Lee; R Mahalingam; A R Hayward
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 5.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.